The Company's representatives will take part in the largest pharmaceutical conference in Europe.
Maciej Wieczorek, CEO of Celon Pharma S.A.: We are increasing the presence of our products abroad, building a strong position in the segment of inhalation products on the global pharmaceutical market; we are observing that companies from around the world are taking a great interest in our innovative R&D projects, and therefore conferences organised by Jefferies will certainly become a fixture on our map of global activities. At the conference, we will focus on presenting the results of our R&D pipeline and continue partnership talks.
The organisers anticipate that over 500 companies and 3,000 participants will take part in the conference this year. Such a large outreach is possible thanks to it being held virtually. Celona Pharma will participate in numerous presentations, as well as one-to-one meetings.
Contact information for registration and booking meetings with our Company: [email protected]
See Company Group PPT here: Celon Pharma at Jefferies